Cyclophosphamide monohydrate
Molecular Structure:
MDL:
MFCD00149395
Molecular Formula:
C7H15Cl2N2O2P·H2O
Molecular Weight:
279.10
Alias:
安道生,環(huán)磷氮芥,癌得星,N,N-雙(β-氯乙基)-N',O-三次甲基磷二酰胺酸酯-水化合物
2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
Cytoxan
Product order:
Name |
Specifications |
Packing |
Price |
Delivery |
Cyclophosphamide monohydrate |
97.0%-103.0%(HPLC) |
1g(原-裝) |
RMB 1353 |
現(xiàn)貨 |
Cyclophosphamide monohydrate |
97% |
1g |
RMB 233.2 |
Consulting service |
Cyclophosphamide monohydrate |
97% |
5g |
RMB 759 |
Consulting service |
Cyclophosphamide monohydrate |
97% |
25g |
RMB 2838 |
Consulting service |
Character:
白色結(jié)晶或結(jié)晶性粉末,微溶于水,微溶于醇、苯、乙二醇、四氯化碳、二氧六圜,幾乎不溶于乙醚及丙酮,失去結(jié)晶水即液化,水溶液不穩(wěn)定,無臭、味微苦。
沸點(diǎn): 110℃
熔點(diǎn):49-53℃
Quality Standard:
外觀Appearance 白色至類白色結(jié)晶或結(jié)晶粉末
紅外光譜鑒別Infrared spectrometry 符合
熔點(diǎn)Melting point 49°C - 53°C
純度Purity ≥97.0% (Titrimetry)
水分Water 6 - 7 %
Storage:
儲(chǔ)存溫度 2-8°C
環(huán)磷酰胺是一種細(xì)胞毒性物,廣泛地用于癌癥化療。它交聯(lián)DNA,引起DNA鏈斷裂,從而誘發(fā)突變。它的臨床活性和醛脫氫酶(aldehyde dehydrogenase 1,ALDH1)活性的減少密切相關(guān)。
Related Products
- Benzophenone imine
- 4-Amino-N,N-diethylaniline
- Dichlormid
- 1H-Pyrazole-3-carboxamide
- 5-Chloro-2-thiophenesulfonamide
- N,N-Dicyclohexylmethylamine
- Diacetone Acrylamide
- 2-Fluorothiobenzamide
- Tryptamine
- 4-Fluorobenzylamine
- p-Xylylenediamine
- Formamide
- 2-Isopropylaniline
- Trichloroacetamide
- N-(N-PROPYL)ETHYLENEDIAMINE
- N-(3-Dimethylaminopropyl)-N'-ethylcarbodiimide
- COLURACETAM
- N-Acetylcaprolactam
- N,N-Diethylhydroxylamine
- TMS-BA
- N,N′-Dicyclohexylcarbodiimide
- Chloramine T trihydrate
- 9-Fluorenylmethyl carbamate
- N,N-Bis(3-aminopropyl)methylamine
- 3-Methoxybenzylamine
- 3,5-Dichlorobenzylamine
- 4-Bromo-2-methylaniline
- 2,4,5-Trimethylaniline solution
- 2-(p-Tolyl)ethylamine
- 3-Azetidinecarboxylic acid
- Methyl 2-(Aminosulfonyl)benzoate
- Erucamide
- N,N-Diphenylcarbamyl chloride
- 1,1-Cyclohexanediacetic acid monoamide
- 3-Methoxydiphenylamine
- O-(Trimethylsilyl)hydroxylamine
- N-(2-Hydroxyethyl)acrylamide, HEAA
- Cyclophosphamide monohydrate
- N-N-Dimethylacetamide
- N-Isopropylacrylamide
- Tris(2-aminoethyl)amine
- 4-Chlorobenzylamine
- N-Hydroxyphthalimide
- L-Buthionine-sulfoximine
- 3-(Dibutylamino)propylamine
- Dicyandiamide
- N-(Methoxymethyl)-N-(trimethylsilylmethyl)benzylamine
- Triethanolamine
- Formanilide
- 3-Bromo-2-methylaniline
- Tris(N,N-tetramethylene)phosphoric acid triamide
- Propargylamine
- Ethanamine
- [3S-(3α,4aβ,8aβ)]-N-(tert-Butyl)decahydro-3-isoquinolinecarboxamide
- Poly(propylene glycol) bis(2-aminopropyl ether)
- 2,5-Diethoxyaniline
- 3,4-Dimethoxyphenethylamine
- (R)-(+)-1-(4-Methylphenyl)ethylamine
- Cinnamamide, Predominantly trans
- N-(2,4-Dimethylphenyl)-3-oxobutyramide
- 3-Ethylaniline
- 3,4,5-Trimethoxyaniline
- GADOPENTETATE MONOMEGLUMINE (500 MG)F1F0940.998MG/MG(AN)
- Octadecanamide
- N-Iodosuccinimide
- N,N,N',N'-Tetramethyl-1,3-propanediamine
- N-Methylformanilide
- 2-Chlorobenzylamine
- DL-1-Amino-2-propanol
- 2,6-Diisopropylaniline
- Salicylamide
- N,N-Diethylformamide
- Cyanoacetamide
- 2-ethylhexyloxypropylamine
- (S)-(-)-2-Methyl-2-propanesulfinamide
- (R)-(+)-1-(2-Naphthyl)ethylamine
- N-(2-Chloroethyl)acetamide
- L-Glutamic acid γ-(β-naphthylamide)
- 3′-Amino-4′-chloroacetanilide
- 4,5-Dichlorothiophene-2-sulfonamide